This hypothesis also reconciles the negative findings of studies evaluating IL-6 inhibitors with the uncontrolled evidence suggesting that IL-1 inhibition might be effective for COVID-19: indeed, IL-1 is found more upstream in inflammatory cascades than IL-6. Here, IL1B is linked to COVID-19.